Lougiakis, N., Madan Renes, V., & Bartenschlager, R. (2017). Novel nucleoside analogues targeting HCV replication through an NS5A‐dependent inhibition mechanism. Chemical biology and drug design, 90(3), . https://doi.org/10.1111/cbdd.12966
Chicago-Zitierstil (17. Ausg.)Lougiakis, Nikolaos, Vanesa Madan Renes, und Ralf Bartenschlager. "Novel Nucleoside Analogues Targeting HCV Replication Through an NS5A‐dependent Inhibition Mechanism." Chemical Biology and Drug Design 90, no. 3 (2017). https://doi.org/10.1111/cbdd.12966.
MLA-Zitierstil (9. Ausg.)Lougiakis, Nikolaos, et al. "Novel Nucleoside Analogues Targeting HCV Replication Through an NS5A‐dependent Inhibition Mechanism." Chemical Biology and Drug Design, vol. 90, no. 3, 2017, https://doi.org/10.1111/cbdd.12966.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.